MedTrace Logo

Observational Registry for Basal Insulin Treatment Study (ORBIT)

NCT01859598 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 19894

Last updated 2016-10-12

Study results available
· View outcomes & findings →

Summary

The scientific use of basal insulin is of great help to individuals and the government. However, there are few studies to investigate the real world use, effect, safety and influence factors of basal insulin in China. This study is to evaluate the use of first basal insulin in China patients with type 2 diabetes with inadequate glycemic control on oral antidiabetic agents (OADs) from the naturalistic clinical practice.

Conditions

Sponsors & Collaborators

  • Chinese Diabetes Society

    collaborator OTHER

  • The George Institute for Global Health, China

    lead OTHER

Principal Investigators

  • Linong Ji, Prof. · The George Institute for Global Health, China

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2014-06-30
Completion
2014-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01859598 on ClinicalTrials.gov